2024. EFFICIENCY OF THE VINORELBINE – CAPECITABINE + BEVASIZUMAB REGIMEN IN THE TREATMENT OF PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER. Web of Medicine: Journal of Medicine, Practice and Nursing . 2, 11 (Nov. 2024), 91–97.